News | October 08, 2021
Lincoln Pharma gets Australian TGA approval
The company plans to expand its portfolio in regulated markets aggressively
The company plans to expand its portfolio in regulated markets aggressively
Cipla is a leading global pharma company
If approved, Gavreto will be the first and only targeted treatment approved by the EMA that includes first-line treatment of people with RET fusion-positive advanced NSCLC
Ind-Ra expects IPM revenue to grow over 12% YoY in FY22
The company's discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Demand normalisation post the second wave contributed to the steady growth
TLD is recommended by WHO, USAID, and PEPFAR as a preferred first-line treatment regimen for the treatment of HIV in adults and pediatric patients weighing at least 35 kg
Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL is AN-rated generic therapeutic equivalent version of Sunovion Pharmaceuticals Inc.’s Brovana
The company expects to see steady performance led by new launches and gradual normalization post the scale-up in vaccination
Subscribe To Our Newsletter & Stay Updated
